Donald W. Reynolds Institute on Aging
Research

Volunteers Needed News from the Chair
Donald W. Reynolds Institute on Aging
Research Areas Introduction
-
Research Areas
-
History of UAMS
Donald W. Reynolds Institute on Aging
Volunteers Needed Research Faculty
Donald W. Reynolds Institute on Aging
Volunteers Needed Senior Advisors
Donald W. Reynolds Institute on Aging
Current Research Funding Application Information
Donald W. Reynolds Institute on Aging
Donald W. Reynolds Institute on Aging

Donald W. Reynolds Institute on Aging Donald W. Reynolds Center of Aging Donald W. Reynolds Center of Aging Home | Contact Us | Getting Here | Site Map   

  The Facility | Patients & Caregivers | AR Aging Initiative
Clinical Care | Faculty | Education | Research
Your Participation | Resources & Publications | About Us

Increase Text Size

 
Donald W. Reynolds Institute on Aging

Senior Advisors - Stavros Manolagas, M.D., Ph.D.

Stavros Manolagas, M.D., Ph.D.

Stavros Manolagas, M.D., Ph.D. is Chief, Section of Endocrinology and Metabolism; Director, Division of Endocrinology/Metabolism; Director, Center for Osteoporosis and Metabolic Bone Diseases; and Professor of Medicine at UAMS. Dr. Manolagas’ clinical interests include metabolic bone disorders, diseases of the parathyroid glands and other calcium disorders, osteoporosis, hormone replacement and women’s health.

His research interests include the interplay among hormones, cytokines, the hematopoietic/immune system and bone; cellular and molecular mechanisms of the pathogenesis of osteoporosis due to estrogen or androgen deficiency, old age, and glucocorticoid excess; and mechanisms of steroid hormone receptor action. Metabolic Bone Diseases; and Professor of Medicine at UAMS. Dr. Manolagas’ clinical interests include metabolic bone disorders, diseases of the parathyroid glands and other calcium disorders, osteoporosis, hormone replacement and women’s health.

Selected Publications:

Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews, 2000. 21:115-137.

Kousteni S, Bellido T, Plotkin LI, O’Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB,  Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC.  Non-Genotropic, sex non-specific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity.  Cell, 2001. 104:719-730.

Di Gregorio GB, Yamamoto M, Abe E, Roberson P, Manolagas SC, Jilka RL.  Attenuation of the self-renewal of transit amplifying osteoblast progenitors in the murine bone marrow by 17b-estradiol. J Clin Invest, 2001. 107:803-812.

Manolagas SC and Kousteni S.  Perspective: Non-reproductive sites of action of reproductive hormones. Endocrinology, 2001. 142:2200-2204.

Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O’Brien CA, Plotkin L, Qiang F, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R,Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC. Reversal of bone loss in mice by nongenotropic signaling of sex steriods. Science, 2002. 298:843-846.

Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T and Manolagas SC. Kinase-mediated regulation of common transcription factors accounts for the bone protective effects of sex steroids. J Clin Invest, 2003. 111:1651-1664.



Donald W. Reynolds Institute on Aging Copyright © 2005
Donald W. Reynolds Institute on Aging

University of Arkansas for Medical Sciences
4301 W. Markham Slot 748
Little Rock, AR 72205
(501) 296-1000
(800) 942-8267
geriatrics@uams.edu Notice of Privacy Practices
HOME CONTACT US GETTING HERE SITE MAP